Full Text View
Tabular View
Study Results
Related Studies
A Study to Evaluate the Safety and Efficacy of Gatifloxacin for the Treatment of Bacterial Conjunctivitis
This study has been completed.
Study NCT00464438   Information provided by Allergan

First Received on April 19, 2007.   Last Updated on August 17, 2011   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Bacterial Conjunctivitis
Additional conditions recognized in this trial
Conjunctivitis
Conjunctivitis, Bacterial
More general conditions related to this trial
Bacterial Infections
Conjunctival Diseases
Eye Diseases
Eye Infections
Eye Infections, Bacterial
Infection
Interventions listed in this trial
gatifloxacin
moxifloxacin 0.5% eye drops
Additional drug interventions recognized in this trial
Moxifloxacin
Norgestimate, ethinyl estradiol drug combination
More general drug interventions related to this trial
Anti-Infective Agents
Contraceptive Agents
Contraceptive Agents, Female
Contraceptives, Oral
Contraceptives, Oral, Combined
Pharmacologic Actions
Physiological Effects of Drugs
Reproductive Control Agents
Therapeutic Uses
Sponsors listed in this trial
Allergan


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services